TGTGInsighttelegram intelligenceLIVE / telegram public index
← πŸ©Ίπ˜Ύπ˜Όπ™π˜Ώπ™„π™Šπ˜Όπ˜Ώπ™„π˜Ύπ™π™Šπ™ŽπŸ«€
πŸ©Ίπ˜Ύπ˜Όπ™π˜Ώπ™„π™Šπ˜Όπ˜Ώπ™„π˜Ύπ™π™Šπ™ŽπŸ«€ avatar

TGINSIGHT POST

Post #3130

@CARDIOADICTOS

πŸ©Ίπ˜Ύπ˜Όπ™π˜Ώπ™„π™Šπ˜Όπ˜Ώπ™„π˜Ύπ™π™Šπ™ŽπŸ«€

쑰회수1,670κ²Œμ‹œλ¬Ό 쑰회수
κ²Œμ‹œλ¨10μ›” 30일2024. 10. 30. AM 10:44
λ‚΄μš©

κ²Œμ‹œλ¬Ό λ‚΄μš©

The CLEAR SYNERGY OASIS 9 trial showed that in patients with #cvAMI undergoing #PCI, daily treatment with #colchicine did not reduce #MACE at 5 years compared with placebo. bit.ly/3YIRb2n #TCT2024 πŸ—žοΈ VΓ­a: American College of Cardiology (ACC).